DNA-damage signals are transduced to activate a key family of phosphoinositide-3-kinase related kinases (PIKKs), including ATM, which phosphorylates a number of proteins essential in the control of cell-cycle checkpoints, DNA repair and, in the case of excessive DNA damage, cell death 1,2,3 . How ATM activity is regulated by the DNA-damage signal is not clear. Previous studies indicate that activation of ATM involves autophosphorylation of several Ser residues including Ser 1981 (refs 4,5). The widely accepted model is that autophosphorylation of ATM at Ser 1981 releases it from the inhibitory homodimer structure, leading to its activation and recruitment to sites of DNA double-strand breaks (DSBs) 6 . However, a recent report questions the role of Ser 1987, the mouse equivalent of Ser 1981, in DNA-damage-induced activation of ATM in vivo 7, .
DNA-damage signals are transduced to activate a key family of phosphoinositide-3-kinase related kinases (PIKKs), including ATM, which phosphorylates a number of proteins essential in the control of cell-cycle checkpoints, DNA repair and, in the case of excessive DNA damage, cell death 1, 2, 3 . How ATM activity is regulated by the DNA-damage signal is not clear. Previous studies indicate that activation of ATM involves autophosphorylation of several Ser residues including Ser 1981 (refs 4,5) . The widely accepted model is that autophosphorylation of ATM at Ser 1981 releases it from the inhibitory homodimer structure, leading to its activation and recruitment to sites of DNA double-strand breaks (DSBs) 6 . However, a recent report questions the role of Ser 1987, the mouse equivalent of Ser 1981, in DNA-damage-induced activation of ATM in vivo 7, .
Unlike proliferating cells, in which DNA damage typically triggers cell-cycle checkpoints, post-mitotic neurons activate their cell-cycle machinery under stress conditions, including genotoxic stimulation 8 . This cell-cycle re-entry by post-mitotic neurons leads to neuronal death; inhibition of such ectopic cell-cycle activity protects neurons [9] [10] [11] [12] .
Studies using ATM -/mice have shown that ATM is required for the p53-mediated apoptosis of developing post-mitotic neurons exposed to ionizing radiation 13, 14 . Suppression of ATM attenuates cell-cycle re-entry and death of post-mitotic neurons induced by the DNA damaging agent camptothecin 15 . These findings establish the role of ATM in neuronal death induced by DNA damage.
Cdk5, a small Ser/Thr kinase regulated by activator p35 but not the cell cycle, has been shown to function in neuronal stress responses [16] [17] [18] . Examination of the protein sequence of ATM revealed the presence of several putative Cdk5 phosphorylation sites. We performed an in vitro Cdk5 kinase assay by incubating purified ATM with purified Cdk5 in complex with its activator p25. Co-incubation of ATM with Cdk5 led to phosphorylation of ATM ( Fig. 1a ). We tested a set of GST-ATM fusion proteins and showed that GST-ATM4 (amino acid residues 772-1102) was robustly phosphorylated by Cdk5 in vitro (Fig. 1b ). Mutation of Ser 794 to Ala (S794A) abolished phosphorylation by Cdk5, suggesting that Cdk5 directly recognizes ATM Ser 794 in vitro.
To demonstrate that ATM is a Cdk5 substrate in cells, we raised a phospho-specific ATM antibody with a synthetic phospho-peptide corresponding to human ATM residues around Ser 794. This phospho-ATM antibody specifically detected wild-type ATM when phosphorylated at Ser 794 by Cdk5 in vitro but not the S794A mutant ( Fig. 1c ). We then showed that the phospho-ATM antibody detected a very low background signal when ATM was expressed alone in HEK293 cells. Co-expression of Cdk5/p25 led to a strong Ser 794 phospho signal (Fig. 1d ). Interestingly, mutation of Ser 1981 to Ala did not affect phosphorylation at Ser 794, indicating that Cdk5 directly phosphorylates ATM at Ser 794 independently of Ser 1981.
To address how phosphorylation of ATM by Cdk5 may regulate ATM activity, we overexpressed wild-type ATM (ATM WT )with or without co-expression of Cdk5/activator in HEK293 cells, immunoprecipitated ATM, and determined ATM activity using an in vitro kinase assay with a standard commercial substrate PHAS-I. Co-expression of Cdk5 strongly activated ATM WT , whereas ATM S794A did not respond to Cdk5 ( Fig. 2a , Supplementary Information, Fig. S1a ). Compared with ATM WT , the phosphomimetic mutant ATM S794D had higher kinase activity ( Fig. 2a , Supplementary Information, Fig. S1b ). Moreover, overexpression of Cdk5/p35 or Cdk5/p25 in HEK293 cells led to a robust activation of endogenous ATM (Fig. 2b) . Thus, phosphorylation at Ser 794 activates ATM kinase activity.
We then tested whether Cdk5 has a role in the activation of ATM following DNA damage in primary cerebellar granule neurons (CGNs) because of their selective degeneration resulting from ATM deficiency. CGNs cultured for 7 days from postnatal day 6-7 rats were exposed to DNA-damaging agents known to cause DSBs in post-mitotic neurons [19] [20] [21] . Compared with the untreated control, all three DNA-damaging agents caused a robust activation of both Cdk5 and ATM kinase activities ( Fig. 2c ). In contrast, the classic apoptosis-inducing agent staurosporine, which typically does not cause DSBs, did not activate either Cdk5 or ATM. Tests of more general cell-death inducers showed that several of them activate both Cdk5 and ATM (Supplementary Information, Fig. S1 ). Interestingly, serum/potassium (S/K) withdrawal, another widely used model of CGN apoptosis not triggered directly by DNA damage, activated Cdk5 without affecting ATM activity. Subcellular fractionation showed that S/K withdrawal caused a delayed activation of Cdk5 only in the cytoplasm and failed to activate Cdk5 in the nucleus ( Supplementary Information, Fig. S1d ). Together, these findings indicate that activation of Cdk5 and ATM in post-mitotic neurons may represent a mode of response to a wider spectrum of signals. As camptothecin was very effective in activating Cdk5 and ATM under our experimental conditions, we used it in subsequent studies.
Because the protease calpain is activated by DNA damage 22 and is involved in the conversion of p35 to the more potent Cdk5 activator p25 (ref. 23 ), we tested whether camptothecin activates Cdk5 by increasing p25. Camptothecin treatment caused a rapid and transient increase in p25 levels, which correlated with an increase in calpain activity, as indicated by the cleavage of α-Fodrin ( Fig. 2d ). Camptothecin-induced activation of Cdk5 paralleled the increase in p25 and preceded activation of nuclear ATM ( Fig. 2e ). Inhibition of calpain with AK295 clearly reduced camptothecin-induced increase of p25 and activation of both Cdk5 and ATM. Together, these findings suggest that calpain-mediated activation of Cdk5 is required for activation of ATM in response to camptothecin in neurons.
Given our data in Fig. 1d , we tested whether Ser 794 phosphorylation regulates autophosphorylation at Ser 1981. We found that Cdk5 increased phosphorylation at Ser 1981 of ATM WT but failed to enhance Ser 1981 phosphorylation of ATM S749A ( Supplementary Information, Fig. S1e ), which showed higher basal Ser 1981 phosphorylation ( Supplementary  Information, Fig. S1f ). We next studied whether Cdk5 affects Ser 1981 phosphorylation of endogenous ATM. As our anti-phospho-ATM Ser 794 antibody was raised using a human ATM immunogen, to achieve maximal antibody effects, we performed the experiments in neurons differentiated from human SH-SY5Y neuroblastoma cells, which are known to express both Cdk5/p35 and ATM 24 . Compared with the low basal signal, camptothecin induced a rapid and robust ATM phosphorylation at Ser 794 in differentiated SH-SY5Y neuronal cells ( Fig. 3a) . Closely correlated with this, camptothecin also caused an increase in ATM phosphorylation at Ser 1981 with somewhat delayed kinetics. Inhibition of Cdk5 using the inhibitor roscovitine or Cdk5 RNAi adenovirus, blocked camptothecin-induced phosphorylation at Ser 794 and Ser 1981 ( Fig. 3a, b) , indicating that Cdk5-mediated Ser 794 phosphorylation precedes, and is required, for ATM autophosphorylation at Ser 1981. l e t t e r s Next, we tested the effects of inhibiting Cdk5 on ATM-mediated phosphorylation of its two well-characterized substrates, p53 and H2AX. Exposure of CGNs to camptothecin increased p53 phosphorylation at Ser 15, a known site targeted directly by ATM but not by Cdk5 ( Supplementary Information, Fig. S1g , h). Inhibition of Cdk5 by roscovitine or Cdk5 RNAi significantly attenuated camptothecininduced ATM activity and p53 phosphorylation at Ser 15 ( Fig. 3c, d ). Immunocytochemistry studies showed that camptothecin induces robust formation of γ-H2AX foci in CGNs. Both roscovitine and Cdk5 RNAi efficiently reduced the number of camptothecin-induced γ-H2AX foci (Fig. 3e, f) . These data suggest that ATM-mediated phosphorylation of p53 and formation of γ-H2AX foci following DSBs requires Cdk5.
The Pro-directed Ser/Thr kinase Cdk5 and other cycle-cell related Cdks share the same basic phosphorylation recognition motif. This raised the possibility that other Cdks may also regulate ATM directly.
To test this, we re-confirmed the specificity of immunoprecipitation ( Supplementary Information, Fig. S1i ) and showed that maximal activation of Cdk5 occurs 30 min after exposure to camptothecin, and preceding ATM activity, which peaks at 60 min (Fig. 4a ), and γH2AX foci formation (Supplementary information, Fig. S2 ). In comparison, although camptothecin activated Cdk2 and 6, their activation did not peak until 2 h after treatment. Furthermore, in vitro kinase assays showed that neither purified Cdk2 nor Cdk6 phosphorylates ATM Ser 794 under our experimental conditions, but they robustly phosphorylated the control substrate histone H1 (Fig. 4b ). Dominant-negative (DN) Cdk2 and Cdk6 had little effect on camptothecin-induced γ-H2AX foci formation in CGNs, whereas Cdk5 DN effectively reduced the number of γ-H2AX foci (Fig. 4c ). The sequential activation of Cdk5, ATM and Cdk2/6 after DSBs suggests that Cdk2 and 6 do not participate in the initial activation of ATM in the CGN model. Previous studies have shown that post-mitotic neurons re-express cell-cycle markers, including Cdk2 and Cdk6, in response to a variety of neuronal death signals, including DNA damage 8, 10 . Our findings ( Fig. 3a) suggest that Cdk5-mediated activation of ATM may be required for stress-induced cell-cycle re-entry of post-mitotic neurons. Analysis by real-time RT-PCR showed that camptothecin increased Cdk2 and Cdk6 mRNA levels in CGNs, whereas roscovitine clearly blocked such increases as early as 30 min after camptothecin, which coincides with the peak activity of Cdk5 and significantly precedes the activation of Cdk2 and Cdk6 ( Fig. 4a, d, e ). This suggests that Cdk5 is responsible findings, we measured the cell cycle using BrdU labelling ( Supplementary  Information, Fig. S3b ). Collectively, these results indicate that Cdk5-ATM regulates DNA-damage-induced re-activation of the cell-cycle machinery in post-mitotic neurons. The transcription factor p53 is a key ATM substrate that mediates responses to DNA damage. Our findings that inhibition of Cdk5 reduces ATM-mediated phosphorylation of p53 suggest that Cdk5 may regulate p53 function through ATM in response to DNA damage. We assessed p53 activity using a luciferase reporter assay in a background without endogenous functional ATM (A-T cells) and in CGNs. Our data show that DNA-damage-induced activation of p53 in CGNs is dependent on Cdk5. ATM mediates Cdk5-induced full activation of p53 activity, which requires Ser 794 but not Ser 1981 ( Supplementary Information, Fig. S4 ).
In response to DNA damage and ATM signalling, p53 activates the expression of many essential downstream target genes related to death, including puma and bax 25 . Real-time RT-PCR analysis showed that camptothecin caused a significant increase in mRNA levels of both puma and bax, whereas roscovitine reduced puma and bax mRNA to near basal levels. Similar results were obtained for additional p53 targets such as PCNA 25 ( Supplementary Information, Fig. S5a-c) . Together, these findings indicate that Cdk5 is required for mediating camptothecin-induced, ATM-dependent expression of p53 target gene expression.
Our findings suggest that phosphorylation of ATM by Cdk5 has a key role in neuronal death induced by DNA damage. We tested this by performing WST-1 survival assays. Our data showed that camptothecin significantly reduced the survival of CGNs, whereas roscovitine was sufficient to block camptothecin-induced death of CGNs in a concentration-dependent manner (Fig. 5a ). Roscovitine and KU-55933 (ref. 26 ) also reduced camptothecin-induced CGN death in a time-dependent manner (Fig. 5b ). Consistent with these results, inhibition of calpain also protected CGNs from camptothecin toxicity (Fig. 5c ).
To confirm these findings, we showed that both knocking down Cdk5 or ATM by RNAi, and overexpressing Cdk5 DN or ATM KD significantly attenuated camptothecin-induced neuronal death ( Fig. 5d , e; Supplementary  Information, Fig. S5d ). Furthermore, ATM S794A effectively decreased camptothecin-induced neuronal death in differentiated SH-SY5Y cells as well (Fig. 5f ). These findings indicate that phosphorylation of ATM at Ser 794 by Cdk5 directly modulates camptothecin-induced death in neurons.
Proper signalling in the presence of DSBs requires conversion of dormant ATM to a highly active form. Our study establishes that phosphorylation of ATM at Ser 794 by Cdk5 is a crucial step in mediating ATM activation induced by DNA damage in post-mitotic neurons. Ser 794 phosphorylation precedes, and is required for, ATM autophosphorylation at Ser 1981, indicating that Ser 794 phosphorylation is a more upstream initiation event. How phosphorylation at Ser 794 leads to ATM activation is not clear at present. It is conceivable that part of the subsequent changes following Ser 794 phosphorylation may also involve regulation of intermolecular interactions of ATM molecules. Whether Ser 794 phosphorylation regulates recruitment of ATM to sites of DSBs by the MRN complex [27] [28] [29] [30] [31] and participates in DNA repair requires further investigation. Our studies used post-mitotic neurons as a model. Whether phosphorylation of ATM by Cdk5 is limited to neural tissue remains to be addressed. As both Cdk5 and ATM are widely expressed by a variety of cell types, including cancers, it is possible that the Cdk5-ATM pathway may be activated following DNA damage in various tissue types. Our findings that agents not known to induce DNA damage, such as chloroquine or mild osmotic shock, can also activate the Cdk5-ATM pathway ( Supplementary  Information, Fig. S6 ) suggests that Cdk5-mediated regulation of ATM may have a role in the cellular response to a broad spectrum of signals.
Cdk5 and ATM are detected in both cytoplasmic and nuclear compartments in neurons. It is interesting to note that although camptothecin activates Cdk5 in both the cytoplasm and nucleus, only nuclear ATM shows significant activation under the same conditions. Similarly, KCl withdrawal induced robust activation of Cdk5 in the cytoplasm, but this failed to cause a significant change in ATM in either the cytoplasm or nucleus. Thus, it seems that under the experimental conditions tested, Cdk5 preferentially activates ATM in the nucleus. This may constitute at least part of a process allowing cells to distinguish between stress signals.
METHODS
Cell culture. CGNs were cultured from Long Evans rats at postnatal day 6 or 7 on plates coated with poly-l-lysine (Sigma-Aldrich) 17 . CGNs were maintained in basal Eagle's medium containing 10% dialysed fetal bovine serum (FBS), 25 mM KCl, 0.1 mg ml -1 gentamycin, 2 mM glutamine and 25 mM glucose. Treatments or transfections were performed 7 days after plating. HEK293 cells and A-T cells (GM05849C cell line, human ATM-deficient fibroblasts) were cultured in DMEM supplemented with 10% FBS. Human SH-SY5Y cells were cultured in DMEM/F-12 supplemented with 10% FBS, and differentiated with 10 μM all-trans-retinoic acid (Sigma-Aldrich) for 6 days and then brain-derived neurotrophic factor (BDNF, 2 nM; Sigma-Aldrich) for another 2 days as described previously 32 .
Chemicals and antibodies. Roscovitine, wortmannin, caffeine, calcium ionophore and glutamate were purchased from Sigma-Aldrich. H 2 O 2 and Hoechst 33258 were from Fisher Scientific. KU-55933 was provided by KuDos. AK-295 was provided by Jonathan D. Glass (Emory University, Atlanta GA). For immunoblotting, rabbit polyclonal anti-p53, mouse monoclonal anti-phospho-p53 (Ser 15), rabbit polyclonal anti-actin, rabbit polyclonal anti-Cdk2 and mouse monoclonal anti-Cdk6 were all from Cell Signaling; mouse monoclonal anti-ATM was from Sigma-Aldrich; rabbit polyclonal anti-ATM from Calbiochem; rabbit polyclonal anti-p35 (N-20) from Santa Cruz; and mouse monoclonal anti-Cdk5 from Neomakers. For immunofluorescence staining, mouse monoclonal anti-γH2AX was from Upstate Biotechnology; rabbit polyclonal anti-GFP from Abcam and fluorescent secondary antibodies from Jackson ImmunoResearch. Antibodies were used at dilutions recommended by the manufacturers.
Generation of anti-phospho-Ser794 ATM antibody.
A rabbit polyclonal phospho-specific antibody against ATM Ser 794 was produced by 21 st Century Biochemicals with a synthetic 16mer phosphopeptide (KLH-coupled) corresponding to residues surrounding Ser 794 of human ATM (acetyl-CLSNATKp-SPNKIASG-amide). Adenoviruses and infection. Human CDK5, ATM and control RNAi adenoviruses were purchased from Millipore. Viruses were added to SH-SY5Y cells after RA-BDNF differentiation. Treatments were performed 24 h after infection.
Cdk5
RNAi lentivirus and infection. To construct the 19-nucleotide (corresponding to rat Cdk5 nt positions 639-657) 35 short hairpin RNA (shRNA) cassettes, two complementary DNA oligonucleotides were chemically synthesized in Invitrogen, annealed, and inserted into pSUPER shuttle vector immediately downstream of the H1 RNA PolIII promoter: 5´-GATCCCC-GAGGATCTTTCGACTGCTA-TTCAAGAGA-TAGCAGTCGAAAGATCCTC-TTTTTGGAAA-3´ and 5´-AGCTTTTCCAAAAA-GAGGATCTTTCGACTGCTA-TCTCTTGAA-TAGCAGTCGAAAGATCCTC-GGG-3´. The RNAi cassettes with H1 promoter were amplified by PCR and subcloned into pFUGW transfer vector 36 . Lentiviruses were produced in HEK293T cells by co-transfection of pFUGW-CDK5i, packaging plasmid p8.91, vesicular stomatitis virus (VSV) envelope expression plasmid (pMD.G). Lentiviruses were concentrated and titred on HEK293T cells. Serial dilutions of the virus were tested to achieve the highest infectivity. Lentiviruses were applied to CGNs on the fourth day in vitro (DIV) and treatments were performed 72 h after infection. Subcellular fractionation. Cytoplasmic and nuclear fractionation was performed using EZ nuclei isolation Kit (Sigma-Aldrich) according to manufacturer's protocol, which involves three cycles of thorough cell lysis and washing. Only the first cytoplasmic lysate and the last nuclear lysate were kept and used in experiments.
Immunoprecipitation and immunoblotting. Lysates were generally prepared with NP-40 lysis buffer (20 mM Tris, pH 8.0, 135 mM NaCl, 1 mM MgCl 2 , 0.1 mM CaCl 2 , 10% glycerol, 1% NP-40, 0.1 mM Na 3 VO 4 , 50 mM β-glycerol phosphate, 10 mM NaF and protease inhibitors from Roche). For immunoblotting by SDS-PAGE analysis, 50-100 μg of protein was used and 100-500 μg of protein was used for immunoprecipitation, incubated with 1-2 μg of the corresponding antibody at 4°C overnight. The immunocomplexes were collected with protein G plus/protein A-agarose (Calbiochem) and washed three times with NP-40 lysis buffer.
ATM and Cdk kinase assays. Active Cdk5/p25, Cdk2/cyclin A or Cdk6/cyclin D3 kinases were purchased from Upstate Biotechnology. In vitro Cdk kinase assay was performed according to the manufacturer's instructions. Briefly, 2 μg of purified ATM or GST-ATM4 fragment recombinant proteins was incubated with active Cdk kinase in Cdk kinase buffer (8 mM MOPS/NaOH pH7.0, 200 nM EDTA) containing 20 μM ATP, 10 μCi of γ-32 P-ATP for 15 min at 30°C. To determine kinase activity of ATM or Cdks in cells, the corresponding immunoprecipitates were washed twice with either ATM kinase buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 4 mM MnCl 2 , 10% glycerol, 1 mM dithiothreitol, and 100 μM Na 3 VO 4 ) or Cdk kinase buffer, and incubated in the kinase buffer containing γ-32 P-ATP and 1 μg of substrate (PHAS-I for ATM kinase assay (Calbiochem) and histone H1 for Cdk kinase assay (Upstate)) for 30 min at 30°C. The reaction was stopped with SDS sample buffer and boiling for 5 min. Phosphorylation of substrates after SDS-PAGE was analysed by autoradiography.
Cell-cycle analysis. Cells were collected by trypsinization, fixed and stained with propidium iodide. Total DNA content was analysed on a FACSCalibur flow cytometer (Becton Dickinson) using the programs BD CompBeads plus BD FACSDiva and FlowJo.
Survival assays. WST-1 assay (Roche) was performed according to the manufacturer's instructions. Briefly, cells were cultured in 24-well plates. After treatments, cells were incubated with WST-1 substrate, a ready-to-use substrate that measures the metabolic activity of viable cells, for 1-4 h, followed by spectrophotometric assay of coloured product. Single-cell survival assays were performed using a viability/cytotoxicity kit (Invitrogen). Briefly, CGNs were stained with ethidium homodimer-1 (EthD-1) without permeabilization. GFP-positive cells with or without EthD-1 staining were counted using an Olympus IX51 fluorescence microscope in a blinded manner. Two hundred or more transfected cells were counted for each treatment. Numbers of dead CGNs were calculated as a percentage of cells with colocalization of EthD-1 and GFP in the total number of GFP-positive cells counted.
Luciferase assays. Transient transfections were performed by the calcium phosphate transfection method (Sigma-Aldrich), as described by the manufacturer, with PG13pyLuc (wild-type p53 reporter) and its corresponding mutant MG13pyLuc (mutant p53 reporter) 37 . The amount of DNA transfected was equalized by addition of a control vector. Treatments were performed 24 h after transfection. Cell lysates were analysed using enhanced luciferase assay kit (BD Bioscience), according to the manufacturer's instructions.
Immunofluorescence microscopy. CGNs were cultured on coverslips coated with poly-l-lysine. Cells were fixed with 3.7% neutral buffered formalin and permeabilized with 0.3% Triton X-100 in PBS, blocked in 5% normal goat serum, and were stained with anti-γH2AX or anti-GFP antibody, followed by the corresponding fluorescent secondary antibodies (Jackson ImmunoResearch). Cells were counterstained with Hoechst 33258, mounted with Vectashield mounting medium (Vector Laboratories), and then analysed with an Olympus BX51 fluorescence microscope. Numbers of γ-H2AX foci in 200 or more CGNs were counted.
Quantitative real-time reverse transcription-polymerase chain reaction. (qRT-PCR). For real-time RT-PCR, the total RNA was extracted using TRIzol reagent (Invitrogen). Total RNA (1 μg) of each sample was reverse-transcribed using SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen) in a 20-µl volume. The amplification was carried out in a total volume of 50 μl, containing 1 µl of each primer, 25 µl platinum SYBR Green qPCR SuperMix-UDG (Invitrogen), 1 µl ROX reference dye and 2 μl of cDNA (1:10 diluted) using ABI PRISM 7000 real-time PCR system, according to the manufacturer's instructions. In each experiment, the 18S ribosomal RNA (18S rRNA) was amplified as a reference standard. Primer sets were designed using OligoPerfect program (Invitrogen). 18S rRNA primers were 18S rRNA-F, 5´-AACGGCTACCACATCCAA-3´; 18S rRNA-R, 5´-GACTCATTCCAATTACAGGGC-3´. Other target gene primers were BAX-F, 5´-TGTTGCTGATGGCAACTTC-3´;
P21-R, 5´-ACACGCTCCCAGACG-TAGTT; PCNA-F, 5´-TTGGAATCCCAGAACAGGAG-3´; PCNA-R, 5´-AGAAAACTTCACCCCGTCCT-3´. All PCR reactions were performed in duplicate. Standard curves (cycle-threshold values versus template concentration) were prepared for each target gene and for the endogenous reference (18S rRNA) in each sample. To confirm the specificity of the PCR reaction, PCR products were electrophoresed on a 1.2% agarose gel.
Statistical analysis. The results were analysed using two-tailed Student's t-tests where appropriate. (e-f) Effects of S794 mutation on ATM autophosphorylation. HEK293 cells were cotransfected with constructs as indicated. After 24 hours, the levels of phospho-S1981 and total ATM were determined by immunoblotting. (g) Cdk5-induced, ATM dependent p53 phosphorylation at S15. Parental A-T cells and ATM complemented A-T cells (GM05849C) were transfected with pcDNA or Cdk5/p25 constructs for 24 hours. Phospho-p53 S15, total p53 and actin were measured by western blotting in lysates. Cdk5 immunoprecipitated was measured for kinase activity (bottom panel). (h) In vitro phosphorylation of p53 at S15 by ATM but not Cdk5. p53 or ATM was overexpressed in HEK293 cells by transient transfection, then immunoprecipitated using corresponding antibodies. The precipitated p53 or ATM was used as substrate in in vitro kinase assays using purified Cdk5 or ATM with cold ATP. The levels of phospho-S15 p53, phospho-S794 ATM or total p53 and ATM were measured by western blotting. (i) Specificity of immunoprecipitation of Cdks. Cdk2, Cdk5 and Cdk6 were immunoprecipitated from the same amount of CGN lysates. The levels of Cdk5 and activity precipitated kinases were determined by immunoblotting and in vitro kinase assay. 
